02172.HK
MicroPort NeuroTech Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 8.06
+0.00%Year over year
Reported trailing growth
- Revenue
- +26.0%
- EBITDA
- +45.0%
- EBIT
- +96.3%
- EPS
- +256.2%
- Free cash flow
- +45.0%
- Operating cash flow
- +29.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +12.1%
- EBITDA
- +24.5%
- EBIT
- +29.6%
- Net income
- +11.1%
- EPS
- +11.4%
- Free cash flow
- -4.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025